BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 16469407)

  • 1. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.
    Meng F; Yamagiwa Y; Ueno Y; Patel T
    J Hepatol; 2006 Jun; 44(6):1055-65. PubMed ID: 16469407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
    Isomoto H; Mott JL; Kobayashi S; Werneburg NW; Bronk SF; Haan S; Gores GJ
    Gastroenterology; 2007 Jan; 132(1):384-96. PubMed ID: 17241887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells.
    Isomoto H; Kobayashi S; Werneburg NW; Bronk SF; Guicciardi ME; Frank DA; Gores GJ
    Hepatology; 2005 Dec; 42(6):1329-38. PubMed ID: 16317687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line.
    Tadlock L; Patel T
    Hepatology; 2001 Jan; 33(1):43-51. PubMed ID: 11124819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
    Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF
    Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes.
    Meng F; Wehbe-Janek H; Henson R; Smith H; Patel T
    Oncogene; 2008 Jan; 27(3):378-86. PubMed ID: 17621267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mcl-1 is regulated by IL-6 and mediates the survival activity of the cytokine in a model of late stage prostate carcinoma.
    Cavarretta IT; Neuwirt H; Zaki MH; Steiner H; Hobisch A; Nemeth JA; Culig Z
    Adv Exp Med Biol; 2008; 617():547-55. PubMed ID: 18497081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational regulation by p38 mitogen-activated protein kinase signaling during human cholangiocarcinoma growth.
    Yamagiwa Y; Marienfeld C; Tadlock L; Patel T
    Hepatology; 2003 Jul; 38(1):158-66. PubMed ID: 12829998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced interleukin-6 expression through MAPK/p38/NF-kappaB signaling pathway and the resultant antiapoptotic effect on endothelial cells through Mcl-1 expression with sIL6-Ralpha.
    Chou CH; Chen SU; Cheng JC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1553-61. PubMed ID: 19931737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma.
    Zhang MX; Gan W; Jing CY; Zheng SS; Yi Y; Zhang J; Xu X; Lin JJ; Zhang BH; Qiu SJ
    Mol Carcinog; 2019 Jan; 58(1):19-30. PubMed ID: 30182496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
    Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
    J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.
    Shimizu T; Yokomuro S; Mizuguchi Y; Kawahigashi Y; Arima Y; Taniai N; Mamada Y; Yoshida H; Akimaru K; Tajiri T
    World J Gastroenterol; 2006 Oct; 12(39):6316-24. PubMed ID: 17072955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line.
    Park J; Tadlock L; Gores GJ; Patel T
    Hepatology; 1999 Nov; 30(5):1128-33. PubMed ID: 10534331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
    Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
    Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.
    Wehbe H; Henson R; Meng F; Mize-Berge J; Patel T
    Cancer Res; 2006 Nov; 66(21):10517-24. PubMed ID: 17079474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.
    Kobayashi S; Werneburg NW; Bronk SF; Kaufmann SH; Gores GJ
    Gastroenterology; 2005 Jun; 128(7):2054-65. PubMed ID: 15940637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.
    Jee SH; Chiu HC; Tsai TF; Tsai WL; Liao YH; Chu CY; Kuo ML
    J Invest Dermatol; 2002 Nov; 119(5):1121-7. PubMed ID: 12445202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.
    Morton SD; Cadamuro M; Brivio S; Vismara M; Stecca T; Massani M; Bassi N; Furlanetto A; Joplin RE; Floreani A; Fabris L; Strazzabosco M
    Oncotarget; 2015 Sep; 6(28):26052-64. PubMed ID: 26296968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met.
    Leelawat K; Leelawat S; Tepaksorn P; Rattanasinganchan P; Leungchaweng A; Tohtong R; Sobhon P
    J Surg Res; 2006 Nov; 136(1):78-84. PubMed ID: 16950403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.